Many recent findings demonstrated that YAP/TAZ and AR signaling serve as the central regulatory mechanisms for prostate tumorigenesis and several cancer-associated pathways can promote YAP/TAZ signaling [14,48]. This evidence concerns the gene AR and medical procedure.